EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:5296 - gemfibrozil
| Formula | C15H22O3 |
| Net Charge | 0 |
| Average Mass | 250.338 |
| Monoisotopic Mass | 250.15689 |
| SMILES | Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 |
| InChI | InChI=1S/C15H22O3/c1-11-6-7-12(2)13(10-11)18-9-5-8-15(3,4)14(16)17/h6-7,10H,5,8-9H2,1-4H3,(H,16,17) |
| InChIKey | HEMJJKBWTPKOJG-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. anti-HIV agent An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus. |
| Applications: | anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. antilipemic drug A substance used to treat hyperlipidemia (an excess of lipids in the blood). antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. hypoglycemic agent A drug which lowers the blood glucose level. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. antiparkinson drug A drug used in the treatment of Parkinson's disease. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| gemfibrozil (CHEBI:5296) has functional parent valeric acid (CHEBI:17418) |
| gemfibrozil (CHEBI:5296) has role analgesic (CHEBI:35480) |
| gemfibrozil (CHEBI:5296) has role anti-anaemic agent (CHEBI:75835) |
| gemfibrozil (CHEBI:5296) has role anti-HIV agent (CHEBI:64946) |
| gemfibrozil (CHEBI:5296) has role antilipemic drug (CHEBI:35679) |
| gemfibrozil (CHEBI:5296) has role antineoplastic agent (CHEBI:35610) |
| gemfibrozil (CHEBI:5296) has role antiparkinson drug (CHEBI:48407) |
| gemfibrozil (CHEBI:5296) has role cardiovascular drug (CHEBI:35554) |
| gemfibrozil (CHEBI:5296) has role hypoglycemic agent (CHEBI:35526) |
| gemfibrozil (CHEBI:5296) has role immunosuppressive agent (CHEBI:35705) |
| gemfibrozil (CHEBI:5296) is a aromatic ether (CHEBI:35618) |
| IUPAC Name |
|---|
| 5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid |
| INNs | Source |
|---|---|
| gemfibrozil | ChemIDplus |
| Gemfibrozilo | ChemIDplus |
| gemfibrozilum | ChemIDplus |
| Synonyms | Source |
|---|---|
| 2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansäure | ChemIDplus |
| 2,2-Dimethyl-5-(2,5-xylyloxy)valeriansäure | ChemIDplus |
| 2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid | ChemIDplus |
| CI-719 | ChEMBL |
| Gemfibrozil | KEGG DRUG |
| NSC-757024 | ChEMBL |
| Brand Names | Source |
|---|---|
| Emfib | ChEMBL |
| Lopid | DrugBank |
| Registry Numbers | Sources |
|---|---|
| Beilstein:1881200 | Beilstein |
| CAS:25812-30-0 | ChemIDplus |
| CAS:25812-30-0 | KEGG DRUG |
| Citations |
|---|